Literature DB >> 17099028

Interstitial lung disease in primary Sjögren syndrome.

Joseph G Parambil1, Jeffrey L Myers, Rebecca M Lindell, Eric L Matteson, Jay H Ryu.   

Abstract

BACKGROUND: Primary Sjögren syndrome (pSS) has been associated with various histologic patterns of interstitial lung disease (ILD).
METHODS: We retrospectively identified 18 patients with pSS and suspected ILD who underwent lung biopsies (14 surgical biopsies and 9 bronchoscopic biopsies) at our institution during a 13-year period from 1992 through 2004. Histopathologic findings were analyzed and correlated with radiologic features and outcome.
RESULTS: Median age was 62 years (range, 34 to 78 years), and 15 patients (83%) were women. Most patients presented with dyspnea and cough. Chest radiographs demonstrated bilateral infiltrates, and high-resolution CT revealed abnormalities of various types including ground-glass, consolidation, reticular, and nodular opacities. The major histopathologic patterns included nonspecific interstitial pneumonia (NSIP) [five patients], organizing pneumonia (OP) [four patients], usual interstitial pneumonia (UIP) [three patients], lymphocytic interstitial pneumonia (three patients), primary pulmonary lymphoma (two patients), and diffuse interstitial amyloidosis (one patient). In four patients (three with OP and one with amyloidosis), the diagnosis was established on transbronchial biopsy results. Treatment commonly included prednisone with or without another immunosuppressive agent. During the follow-up period (median, 38 months), most patients improved or remained stable except three patients with UIP, one patient with NSIP, and one patient with amyloidosis. Seven patients (39%) died, including three deaths from acute exacerbation of interstitial pneumonia.
CONCLUSIONS: A variety of histologic patterns can be seen in patients with pSS-associated ILD. Those with UIP tended to have progression of lung disease. Death from acute exacerbation of interstitial pneumonia may occur in patients with pSS-associated ILD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099028     DOI: 10.1378/chest.130.5.1489

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  73 in total

1.  Pulmonary manifestations of systemic autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Bucur)       Date:  2011-07

2.  Rapid progressive interstitial lung disease as initial manifestation of primary Sjögren's syndrome: a case report.

Authors:  Yihua Lin; Qun Yi; Deyun Cheng
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.

Authors:  Evans R Fernández-Pérez; Murat Yilmaz; Hussam Jenad; Craig E Daniels; Jay H Ryu; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

4.  Pirfenidone for primary Sjögren's syndrome-related fibrotic interstitial pneumonia.

Authors:  Yasunori Enomoto; Yutaro Nakamura; Thomas V Colby; Naoki Inui; Takafumi Suda
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 5.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

Review 6.  Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

Authors:  Aryeh Fischer; Jörg Distler
Journal:  Clin Rheumatol       Date:  2019-08-19       Impact factor: 2.980

7.  Characterisation of patients with interstitial pneumonia with autoimmune features.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Eleanor Valenzi; Cathryn Lee; Leah Witt; Lena Chen; Aliya N Husain; Steven Montner; Jonathan H Chung; Vincent Cottin; Aryeh Fischer; Imre Noth; Rekha Vij; Mary E Strek
Journal:  Eur Respir J       Date:  2016-04-21       Impact factor: 16.671

8.  Clinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia.

Authors:  Esam H Alhamad
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

9.  Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara S McCoy; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2018-01-31       Impact factor: 5.532

Review 10.  Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.

Authors:  Flavia V Castelino; John Varga
Journal:  Arthritis Res Ther       Date:  2010-08-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.